Transcriptome profiling of human FoxP3+ regulatory T cells

Human Immunology

Volumn 77, Issue 2, 2016, Pages 201-213

  Bhairavabhotla, Ravikiran ^a,c   Kim, Yong C ^a,d   Glass, Deborah D ^a   Escobar, Thelma M ^a,e   Patel, Mira C ^b,f   Zahr, Rami ^a   Nguyen, Cuong K ^a,g   Kilaru, Gokhul K ^a,h   Muljo, Stefan A ^a   Shevach, Ethan M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNITED NATIONS   (United States)

^d Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g Institute of Population Health and Development   (Viet Nam)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Differentially expressed; FoxP3; Gene signature; LAYN; MiR 146a; MiR 146b; MiR 21; MiRNA; nCounter analysis; PNA; RNA sequencing; RTKN2; Suppressive cells

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IKZF2 PROTEIN; MICRORNA; MICRORNA 125A 5P; MICRORNA 146A; MICRORNA 146B 5P; MICRORNA 21; MICRORNA 28 3P; MICRORNA 31; MICRORNA 34A; MICRORNA 598; MICRORNA 660; MICRORNA LET 7G; PEPTIDES AND PROTEINS; POLYADENYLATED RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTOME; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; LAYN PROTEIN, HUMAN; LECTIN; RTKN2 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ANIMAL CELL; ARTICLE; CD70 GENE; CECAM4 GENE; CONTROLLED STUDY; CSF2RB GENE; ENC1 GENE; F5 GENE; GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOGENETICS; IN VITRO STUDY; LAYN GENE; MOUSE; NKG7 GENE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RNA SEQUENCE; RTKN2 GENE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTOMICS; TRIB1 GENE; UTS2 GENE; CELL CULTURE; GENE REGULATORY NETWORK; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; GENE REGULATORY NETWORKS; HUMANS; IMMUNE TOLERANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LECTINS, C-TYPE; MICRORNAS; RNA, SMALL INTERFERING; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTOME;

EID: 84958104365     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2015.12.004     Document Type: Article

References (47)

1. Ohkura N., Kitagawa Y., Sakaguchi S. Development and maintenance of regulatory T cells. Immunity 2013, 38:414-423.
2. Bacchetta R., Passerini L., Gambineri E., Dai M., Allan S.E., Perroni L., et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 2006, 116:1713-1722.
3. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001, 27:20-21.
4. Sgouroudis E., Piccirillo C. Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons from mouse models and implications for human disease. Diabetes Metab. Res. Rev. 2009, 25:208-218.
5. Bettini M.L., Vignali D.A. Development of thymically derived natural regulatory T cells. Ann. N. Y. Acad. Sci. 2010, 1183:1-12.
6. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3. Immunity 2005, 22:329-341.
7. Tran D.Q., Ramsey H., Shevach E.M. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007, 110:2983-2990.
8. van der Veeken J., Arvey A., Rudensky A. Transcriptional Control of Regulatory T-Cell Differentiation. Cold Spring Harb. Symp. Quant. Biol. 2013, 78:215-222.
9. Pfoertner S., Jeron A., Probst-Kepper M., Guzman C.A., Hansen W., Westendorf A.M., et al. Signatures of human regulatory T cells: an encounter with old friends and new players. Genome Biol. 2006, 7:R54.
10. Sugimoto N., Oida T., Hirota K., Nakamura K., Nomura T., Uchiyama T., et al. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 2006, 18:1197-1209.
11. McManus M.T., Sharp P.A. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 2002, 3:737-747.
12. Chong M.M., Rasmussen J.P., Rudensky A.Y., Littman D.R. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J. Exp. Med. 2008, 205:2005-2017.
13. Liston A., Lu L.F., O'Carroll D., Tarakhovsky A., Rudensky A.Y. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 2008, 2008(205):1993-2004.
14. Lu L.F., Boldin M.P., Chaudhry A., Lin L.L., Taganov K.D., Hanada T., et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010, 142:914-929.
15. Lu L.F., Thai T.H., Calado D.P., Chaudhry A., Kubo M., Tanaka K., et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009, 30:80-91.
16. Jeker L.T., Zhou X., Blelloch R., Bluestone J.A. DGCR8-mediated production of canonical microRNAs is critical for regulatory T cell function and stability. PLoS One 2013, 8:e66282.
17. Ferraro A., D'Alise A.M., Raj T., Asinovski N., Phillips R., Ergun A., et al. Interindividual variation in human T regulatory cells. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:E1111-E1120.
18. Fu W., Ergun A., Lu T., Hill J.A., Haxhinasto S., Fassett M.S., et al. A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells. Nat. Immunol. 2012, 13:972-980.
19. Birzele F., Fauti T., Stahl H., Lenter M.C., Simon E., Knebel D., et al. Next-generation insights into regulatory T cells: expression profiling and FoxP3 occupancy in Human. Nucleic Acids Res. 2011, 39:7946-7960.
20. Sadlon T.J., Wilkinson B.G., Pederson S., Brown C.Y., Bresatz S., Gargett T., et al. Genome-Wide Identification of Human FOXP3 Target Genes in Natural Regulatory T Cells. J. Immunol. 2010, 185:1071-1081.
21. Kim Y.C., Bhairavabhotla R., Yoon J., Golding A., Thornton A.M., Tran D.Q., et al. Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansion. Blood 2012, 119:2810-2818.
22. Thornton A.M., Korty P.E., Tran D.Q., Wohlfert E.A., Murray P.E., Belkaid Y., et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 2010, 184:3433-3441.
23. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 2009(10):R25.
24. Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., et al. The human genome browser at UCSC. Genome Res. 2002, 12:996-1006.
25. Wang L., Feng Z., Wang X., Wang X., Zhang X. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 2010, 26:136-138.
26. Alder H., Taccioli C., Chen H., Jiang Y., Smalley K.J., Fadda P., et al. Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis 2012, 33:1736-1744.
27. Geiss G.K., Bumgarner R.E., Birditt B., Dahl T., Dowidar N., Dunaway D.L., Fell H.P., et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat. Biotechnol. 2008, 26:317-325.
28. Tran D.Q., Glass D.D., Uzel G., Darnell D.A., Spalding C., Holland S.M., et al. Analysis of adhesion molecules, target cells, and role of IL-in human FOXP3+ regulatory T cell suppressor function. J. Immunol. 2009, 182:2929-2938.
29. Tran D.Q., Andersson J., Hardwick D., Bebris L., Illei G.G., Shevach E.M. Selective expression of latency-associated peptide (LAP) and IL-receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. Blood 2009, 113:5125-5133.
30. Putnam A.L., Brusko T.M., Lee M.R., Liu W., Szot G.L., Ghosh T., et al. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 2009, 58:652-662.
31. Tang Q., Bluestone J.A. Regulatory T-cell therapy in transplantation: moving to the clinic. Cold Spring Harb. Perspect. Med. 2013, 3:a015552.
32. Oh S.Y., Ju Y., Kim S., Park H. PNA-based antisense oligonucleotides for micrornas inhibition in the absence of a transfection reagent. Oligonucleotides 2010, 20:225-230.
33. Smigielska-Czepiel K., van den Berg A., Jellema P., van der Lei R.J., Bijzet J., Kluiver J., et al. Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs. Genes Immun. 2014, 15:115-125.
34. Tran D.Q., Andersson J., Wang R., Ramsey H., Unutmaz D., Shevach E.M. GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13445-13450.
35. Collier F.M., Gregorio-King C.C., Gough T.J., Talbot C.D., Walder K., Kirkland M.A. Identification and characterization of a lymphocytic Rho-GTPaseFig effector: rhotekin-2. Biochem. Biophys. Res. Commun. 2004, 324:1360-1369.
36. + Lymphocytes. J. Cell Death 2009, 2:9-23.
37. Myouzen K., Kochi Y., Okada Y., Terao C., Suzuki A., Ikari K., et al. Functional variants in NFKBIE and RTKN2 involved in activation of the NF-kappaB pathway are associated with rheumatoid arthritis in Japanese. PLoS Genet. 2012, 8:e1002949.
38. Bono P., Rubin K., Higgins J.M., Hynes R.O. Layilin, a novel integral membrane protein, is a hyaluronan receptor. Mol. Biol. Cell 2001, 12:891-900.
39. Borowsky M.L., Hynes R.O. Layilin, a novel talin-binding transmembrane protein homologous with C-type lectins, is localized in membrane ruffles. J. Cell Biol. 1998, 143:429-442.
40. Murata M., Yudoh K., Shimizu H., Beppu M., Nakamura H., Kato T., et al. Layilin, a talin-binding hyaluronan receptor, is expressed in human articular chondrocytes and synoviocytes and is down-regulated by interleukin-1beta. Mod. Rheumatol. 2013, 23:478-488.
41. Chen Z., Zhuo W., Wang Y., Ao X., An J. Down-regulation of layilin, a novel hyaluronan receptor, via RNA interference, inhibits invasion and lymphatic metastasis of human lung A549 cells. Biotechnol. Appl. Biochem. 2008, 50:89-96.
42. Pan F., Yu H., Dang E.V., Barbi J., Pan X., Grosso J.F., Jinasena D., et al. Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 2009, 325:1142-1146.
43. Roychoudhuri R., Hirahara K., Mousavi K., Clever D., Klebanoff C.A., Bonelli M., Sciumè G., et al. BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis. Nature 2013, 498:506-510.
44. Fayyad-Kazan H., Rouas R., Fayyad-Kazan M., Badran R., El Zein N., Lewalle P., et al. MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function. J. Biol. Chem. 2012, 287:9910-9922.
45. Hezova R., Slaby O., Faltejskova P., Mikulkova Z., Buresova I., Raja K.R., et al. MicroRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cell. Immunol. 2010, 260:70-74.
46. Zhou Q., Haupt S., Kreuzer J.T., Hammitzsch A., Proft F., Neumann C., et al. Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2015, 74:1265-1274.
47. Rouas R., Fayyad-Kazan H., El Zein N., Lewalle P., Rothe F., Simion A., et al. Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur. J. Immunol. 2009, 39:1608-1618.